Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This latest feature of MassDevice.com’s coverage highlights our three biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
If you read nothing else today, make sure you’re still in the know with MassDevice +3.
3. Judge grants Ex-Stryker Biotech exec’s request to sever charges in fraud case
A Massachusetts federal judge has granted a request by former Stryker Biotech president Mark Philip to sever charges against him in an ongoing government case that alleges the company, along with former executives, committed conspiracy to defraud the FDA, conspiracy to commit wire fraud and wire fraud.
Sign up to get our free newsletters delivered straight to your inbox
2. St. Jude’s Libra helps patients with Parkinson’s
A deep brain stimulation implant made by St. Jude Medical’s (NYSE:STJ) proved effective in the treatment of patients Parkinson’s disease, according to results published in The Lancet.
1. Boston Scientific aims for double-digit EPS growth
Boston Scientific is looking to shave up to $750 million in costs from its budget – including an estimated $150 million hit from the medical device tax – interim CEO Hank Kucheman told analysts at the J.P. Morgan health care conference.